Tianshi Capital
Overview
Tianshi Capital is an international family office specializing in early-stage investments within the life sciences sector. The firm focuses on angel to Series A investments, typically ranging from $1 million to $2 million USD. Their portfolio encompasses companies in healthcare IT, biotechnology, pharmaceuticals, and agriculture. The founders of Tianshi Capital have over 30 years of experience in building and selling life sciences companies, including pharmaceutical, clinical research, and drug development firms. They are also primary shareholders in various health care IT, biotech, pharmaceutical, and agriculture businesses. Tianshi Capital's investment strategy emphasizes identifying and nurturing innovative companies with high growth potential in the life sciences industry, aiming to drive advancements in healthcare and related fields.
Investment Focus
- Innovative business models
- Strong management teams
- Scalable growth potential
- Alignment with life sciences sector
Reach Tianshi Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Tianshi Capital
What sectors does Tianshi Capital invest in?
Tianshi Capital invests in Healthcare, Agriculture, Life Sciences, Pharmaceuticals and Biotechnology, and is based in Singapore. Tianshi Capital is listed as a family office in the ConnectSafely investor database.
What stage does Tianshi Capital invest at?
Tianshi Capital backs companies at Seed, Early Stage and Series A, writing cheques of 1M - 2M.
Which regions does Tianshi Capital invest in?
Tianshi Capital invests across United States, Europe and China.
Last updated · Source: ConnectSafely investor database